El ayuno intermitente y sus efectos en la salud metabólica en humanos

Intermittent fasting (IF) has gained increasing scientific and general attention. Most studied forms of IF include alternate-day fasting, modified time-restricted eating (TRE). Several cardiometabolic effects have been described in animal models and, to a lesser extent, humans. This review analyzes the impact on weight loss, glucose metabolism, blood pressure, lipid profile A literature search was conducted Pubmed/Medline, Scopus, Google Scholar databases. Controlled observational or interventional studies humans, published between January 2000 June 2021, were included. Studies comparing versus religious not indicate that different types significant benefits body composition, inducing loss reducing fat mass. Changes parameters show more divergent results. In general, decrease insulin levels is observed, together with an improved associated cardiovascular risk. High heterogeneity study designs particularly TRE, small sample sizes, short-term interventions. Current evidence shows confers range Weight improvement homeostasis profile, are observed three protocols evaluated.